Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 324533

Sort by

Sort Order Select

Journal Articles

Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors

Jaclyn Andricovich, Coen Johannes Lap, Alexandros Tzatsos

Blood blood.2024026417.

https://doi.org/10.1182/blood.2024026417

Published: 2025

Includes: Supplemental data

Journal Articles

LRRC8 complexes are ATP release channels regulating platelet activation and arterial thrombosis

Blood blood.2024026667.

https://doi.org/10.1182/blood.2024026667

Published: 2025

Includes: Multimedia, Supplemental data

Journal Articles

Bone marrow neutrophil progenitors suppress osteoclast formation in murine cortical and trabecular bone

Tsuyoshi Isojima, Blessing Crimeen-Irwin, Narelle E McGregor, Ryan C Chai, Ingrid J Poulton, Emma C Walker, Mriga Dutt, Benjamin L Parker, Natalie A Sims

Blood blood.2025028310.

https://doi.org/10.1182/blood.2025028310

Published: 2025

Includes: Supplemental data

Journal Articles

Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell Lymphoma

Blood blood.2025028412.

https://doi.org/10.1182/blood.2025028412

Published: 2025

Includes: Supplemental data

Journal Articles

cMPL-based purification and depletion of human hematopoietic stem cells: implications for pretransplant conditioning

Daisuke Araki, So Gun Hong, Nathaniel Linde, Bryan Fisk, Neelam Redekar, Christi Salisbury-Ruf, Allen Krouse, Theresa Engels, Justin Golomb, Pradeep Dagur, Sumith R. Panicker, Yogendra Kanthi, Diogo M. Magnani, Zhirui Wang, Andre Larochelle

Blood (2025) 145 (25): 2978–2991.

https://doi.org/10.1182/blood.2024024636

Published: 2025

Includes: Supplemental data

Journal Articles

The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy

Blood (2025) 145 (25): 3007–3014.

https://doi.org/10.1182/blood.2024026455

Published: 2025

Includes: Supplemental data

Journal Articles

Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study

Guy Young, Kaan Kavakli, Robert Klamroth, Tadashi Matsushita, Flora Peyvandi, Steven W. Pipe, Savita Rangarajan, Ming-Ching Shen, Alok Srivastava, Jing Sun, Huyen Tran, Chur-Woo You, Bülent Zülfikar, Laurel A. Menapace, Chuanwu Zhang, Yuqian Shen, Marja Puurunen, Marek Demissie, Gili Kenet

Blood (2025) 145 (25): 2966–2977.

https://doi.org/10.1182/blood.2024027008

Published: 2025

Includes: Supplemental data

Journal Articles

Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia

Blood (2025) 145 (25): 3041–3051.

https://doi.org/10.1182/blood.2024027543

Published: 2025

Includes: Supplemental data

Journal Articles

How I treat type 1 plasminogen deficiency

Amy D. Shapiro, Charles Nakar

Blood (2025) 145 (25): 2954–2965.

https://doi.org/10.1182/blood.2024026973

Published: 2025

Includes: Supplemental data

Journal Articles

Beyond genotype: challenges in predicting disease risk for carriers of biallelic perforin variants

Blood (2025) 145 (25): 2992–3006.

https://doi.org/10.1182/blood.2024027954

Published: 2025

Includes: Supplemental data

Journal Articles

Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status

Ciara L. Freeman, Srimathi Srinivasan, Brendan Hodkinson, Sanjay Deshpande, Todd Henninger, Merrill Boyle, Michael L. Wang, Martin Dreyling, David W. Scott

Blood (2025) 145 (25): 3052–3056.

https://doi.org/10.1182/blood.2024026003

Published: 2025

Includes: Supplemental data

Journal Articles

PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target

Qingyu Luo, Amanda L. Fortune, Andrew A. Lane

Blood (2025) 145 (25): 2945–2953.

https://doi.org/10.1182/blood.2024027376

Published: 2025

Journal Articles

Destabilization of PF4-antigenic complexes in heparin-induced thrombocytopenia

Lubica Rauova, Khalil Bdeir, Ann H. Rux, Manu Thomas Kalathottukaren, Jenna Oberg, Chanel C. La, David T. E. Lim, Vincent Hayes, Gavin T. Koma, Amrita Sarkar, Mortimer Poncz, Jayachandran N. Kizhakkedathu, Douglas B. Cines

Blood (2025) 145 (25): 3030–3040.

https://doi.org/10.1182/blood.2024025653

Published: 2025

Includes: Supplemental data

Journal Articles

Blood-based proteomic profiling identifies OSMR as a novel biomarker of AML outcomes

Blood (2025) 145 (25): 3015–3029.

https://doi.org/10.1182/blood.2024027244

Published: 2025

Includes: Supplemental data

Journal Articles

Maternal Tmprss6 is required for hepcidin suppression and fetal health

Katherine L. Fielding, Cavan Bennett, Anne Pettikiriarachchi, Naomi Jones, Rebecca Harding, Alistair R. D. McLean, Louise Randall, Ute Schaeper, Alberto Martinez, Ricardo Ataíde, Sant-Rayn Pasricha

Blood (2025) 145 (25): 3056–3059.

https://doi.org/10.1182/blood.2024027563

Published: 2025

Includes: Supplemental data

Journal Articles

Socioeconomic factors and transplant access

Blood (2025) 145 (25): 3061.

https://doi.org/10.1182/blood.2025029815

Published: 2025

Journal Articles

Genetic challenges in the hole puncher

Randy Q. Cron

Blood (2025) 145 (25): 2934–2936.

https://doi.org/10.1182/blood.2025029039

Published: 2025

Journal Articles

A natural head start to MRD negativity in multiple myeloma

Erin W. Meermeier

Blood (2025) 145 (25): 2936–2937.

https://doi.org/10.1182/blood.2025028710

Published: 2025

Journal Articles

Maternal regulation of iron metabolism resolved?

Léon Kautz

Blood (2025) 145 (25): 2942–2944.

https://doi.org/10.1182/blood.2025029469

Published: 2025

Journal Articles

OSMR takes the leap: from NULISA to ELISA

Tobias Herold

Blood (2025) 145 (25): 2938.

https://doi.org/10.1182/blood.2025029317

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors

LRRC8 complexes are ATP release channels regulating platelet activation and arterial thrombosis

Bone marrow neutrophil progenitors suppress osteoclast formation in murine cortical and trabecular bone

Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell Lymphoma

cMPL-based purification and depletion of human hematopoietic stem cells: implications for pretransplant conditioning

The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy

Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study

Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia

How I treat type 1 plasminogen deficiency

Beyond genotype: challenges in predicting disease risk for carriers of biallelic perforin variants

Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status

PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target

Destabilization of PF4-antigenic complexes in heparin-induced thrombocytopenia

Blood-based proteomic profiling identifies OSMR as a novel biomarker of AML outcomes

Maternal Tmprss6 is required for hepcidin suppression and fetal health

Socioeconomic factors and transplant access

Genetic challenges in the hole puncher

A natural head start to MRD negativity in multiple myeloma

Maternal regulation of iron metabolism resolved?

OSMR takes the leap: from NULISA to ELISA

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only